Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
COYA holding history
Coya Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
COYA overviewAll 13F holders of COYAFull Q2 2026 holdings
- Shares (Q2 2026)
- 82,106
- Value
- $480.3K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 82,106 | $480.3K | <0.1% | −3,594−4.2% | Reduced | Holders |
| Q1 2026 | 85,700 | $337.7K | <0.1% | +32,344+60.6% | Added | Holders |
| Q4 2025 | 53,356 | $309.5K | <0.1% | +51,831+3,398.8% | Added | Holders |
| Q3 2025 | 1,525 | $8.69K | <0.1% | +725+90.6% | Added | Holders |
| Q2 2025 | 800 | $4.60K | <0.1% | −5,940−88.1% | Reduced | Holders |
| Q1 2025 | 6,740 | $43.6K | <0.1% | +3,940+140.7% | Added | Holders |
| Q4 2024 | 2,800 | $16.0K | <0.1% | +2,000+250.0% | Added | Holders |
| Q3 2024 | 800 | $5.16K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 800 | $4.85K | <0.1% | +268+50.4% | Added | Holders |
| Q1 2024 | 532 | $5.28K | <0.1% | +32+6.4% | Added | Holders |
| Q4 2023 | 500 | $3.71K | <0.1% | −1−0.2% | Reduced | Holders |
| Q3 2023 | 501 | $1.92K | <0.1% | +301+150.5% | Added | Holders |
| Q2 2023 | 200 | $814 | <0.1% | +200 | New | Holders |